Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Federal judges in Texas and Connecticut on Thursday ruled against arguments challenging the constitutionality of the Medicare ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Three federal courts reject legal challenges to Medicare drug price negotiation Judges side with government in cases filed by ...

The negotiated drugs include those that are frequently dispensed as well as those that are the most expensive.

All other drugs listed cost the program under $2 billion. Medicare Part D spent the least on Otezla at $995 million, with 31,000 enrollees who used that medication, according to the fact sheet.

Pharmaceutical companies were dealt back-to-back blows over the last 24 hours in their fight against the Biden-era Medicare ...

More than half of the drugs – 13 out of 25 – in the first and second rounds of negotiations would have been ineligible at the time they were selected if the discrepancy between small-molecule ...

The Department of Health and Human Services did not respond to a request for comment on the status of negotiations. Medicare is negotiating the prices of 15 drugs, including Novo Nordisk's Ozempic.

Medicare drug price negotiation is still relatively new. Until the 2022 passage of the Inflation Reduction Act, Medicare part D, which covers more than 50 million seniors, didn't have the ...